Functional electrical stimulation-assisted cycle ergometry-based progressive mobility programme for mechanically ventilated patients: randomised controlled trial with 6 months follow-up.


Journal

Thorax
ISSN: 1468-3296
Titre abrégé: Thorax
Pays: England
ID NLM: 0417353

Informations de publication

Date de publication:
07 2021
Historique:
received: 07 07 2020
revised: 15 03 2021
accepted: 06 04 2021
pubmed: 2 5 2021
medline: 14 7 2021
entrez: 1 5 2021
Statut: ppublish

Résumé

Functional electrical stimulation-assisted cycle ergometry (FESCE) enables in-bed leg exercise independently of patients' volition. We hypothesised that early use of FESCE-based progressive mobility programme improves physical function in survivors of critical care after 6 months. We enrolled mechanically ventilated adults estimated to need >7 days of intensive care unit (ICU) stay into an assessor-blinded single centre randomised controlled trial to receive either FESCE-based protocolised or standard rehabilitation that continued up to day 28 or ICU discharge. We randomised in 1:1 ratio 150 patients (age 61±15 years, Acute Physiology and Chronic Health Evaluation II 21±7) at a median of 21 (IQR 19-43) hours after admission to ICU. Mean rehabilitation duration of rehabilitation delivered to intervention versus control group was 82 (IQR 66-97) versus 53 (IQR 50-57) min per treatment day, p<0.001. At 6 months 42 (56%) and 46 (61%) patients in interventional and control groups, respectively, were alive and available to follow-up (81.5% of prespecified sample size). Their Physical Component Summary of SF-36 (primary outcome) was not different at 6 months (50 (IQR 21-69) vs 49 (IQR 26-77); p=0.26). At ICU discharge, there were no differences in the ICU length of stay, functional performance, rectus femoris cross-sectional diameter or muscle power despite the daily nitrogen balance was being 0.6 (95% CI 0.2 to 1.0; p=0.004) gN/m Early delivery of FESCE-based protocolised rehabilitation to ICU patients does not improve physical functioning at 6 months in survivors. NCT02864745.

Identifiants

pubmed: 33931570
pii: thoraxjnl-2020-215755
doi: 10.1136/thoraxjnl-2020-215755
pmc: PMC8223653
doi:

Banques de données

ClinicalTrials.gov
['NCT02864745']

Types de publication

Journal Article Randomized Controlled Trial Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

664-671

Commentaires et corrections

Type : CommentIn

Informations de copyright

© Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Références

JAMA. 2008 Oct 8;300(14):1685-90
pubmed: 18840842
Intensive Care Med. 2016 May;42(5):725-738
pubmed: 27025938
N Engl J Med. 2011 Apr 7;364(14):1293-304
pubmed: 21470008
Crit Care Med. 2020 Jul;48(7):1055-1065
pubmed: 32345834
J Crit Care. 2014 Aug;29(4):695.e1-7
pubmed: 24768534
J Spinal Cord Med. 2015 Jan;38(1):23-37
pubmed: 25001669
Crit Care. 2010;14(2):R74
pubmed: 20426834
Chest. 2003 Jul;124(1):292-6
pubmed: 12853536
N Engl J Med. 2008 Mar 27;358(13):1327-35
pubmed: 18367735
N Engl J Med. 2014 Apr 24;370(17):1626-35
pubmed: 24758618
Am J Physiol. 1996 Jul;271(1 Pt 2):R191-9
pubmed: 8760220
JAMA. 2018 Jul 24;320(4):368-378
pubmed: 30043066
Lancet. 2009 May 30;373(9678):1874-82
pubmed: 19446324
Crit Care. 2015 Mar 29;19:127
pubmed: 25888469
AACN Clin Issues. 2002 May;13(2):263-76
pubmed: 12011598
Health Serv Res. 2005 Apr;40(2):577-91
pubmed: 15762908
Crit Care Med. 2016 Jun;44(6):1145-52
pubmed: 26968024
Am J Respir Crit Care Med. 2016 May 15;193(10):1101-10
pubmed: 26651376
Crit Care Med. 2007 Jan;35(1):139-45
pubmed: 17133183
Clin Rehabil. 2015 Nov;29(11):1051-63
pubmed: 25681407
J Crit Care. 2015 Feb;30(1):32-9
pubmed: 25307979
Trials. 2019 Dec 16;20(1):724
pubmed: 31842936
Intensive Care Med. 2015 May;41(5):865-74
pubmed: 25851383
JAMA. 2016 Jun 28;315(24):2694-702
pubmed: 27367766
Medicine (Baltimore). 2018 Nov;97(46):e13012
pubmed: 30431575
Crit Care. 2013 Jul 24;17(4):R156
pubmed: 23883525
Thorax. 2018 Mar;73(3):213-221
pubmed: 28780504
CMAJ. 2008 Mar 11;178(6):725-6
pubmed: 18332388
Crit Care. 2008;12(6):238
pubmed: 19040777
Thorax. 2021 Jul;76(7):656-663
pubmed: 33323480
Intensive Care Med. 2014 Apr;40(4):548-55
pubmed: 24477456
J Rehabil Med. 2017 Jan 19;49(1):40-48
pubmed: 28101565
Mitochondrion. 2015 Mar;21:106-12
pubmed: 25701243
Phys Ther. 2013 Dec;93(12):1636-45
pubmed: 23886842
JAMA. 2013 Oct 16;310(15):1591-600
pubmed: 24108501
Yale J Biol Med. 2012 Jun;85(2):201-15
pubmed: 22737049
Assist Technol. 1999;11(2):88-96
pubmed: 11010069
Arch Phys Med Rehabil. 2018 Jun;99(6):1220-1225
pubmed: 29580936
Crit Care. 2016 Jan 29;20:30
pubmed: 26825278
Phys Ther. 2014 Oct;94(10):1499-507
pubmed: 24810863
Crit Care. 2009;13(5):R161
pubmed: 19814793
PLoS One. 2019 Mar 1;14(3):e0200228
pubmed: 30822305

Auteurs

Petr Waldauf (P)

Department of Anaesthesiology and Intensive Care Medicine, 3rd Faculty of Medicine and FNKV University Hospital, Charles University, Prague, Czech Republic.

Natália Hrušková (N)

Department of Rehabilitation, 3rd Faculty of Medicine and FNKV University Hospital, Charles University, Prague, Czech Republic.

Barbora Blahutova (B)

Department of Anaesthesiology and Intensive Care Medicine, 3rd Faculty of Medicine and FNKV University Hospital, Charles University, Prague, Czech Republic.

Jan Gojda (J)

Department of Internal Medicine, 3rd Faculty of Medicine and FNKV University Hospital, Charles University, Prague, Czech Republic.

Tomáš Urban (T)

Department of Anaesthesiology and Intensive Care Medicine, 3rd Faculty of Medicine and FNKV University Hospital, Charles University, Prague, Czech Republic.

Adéla Krajčová (A)

Department of Anaesthesiology and Intensive Care Medicine, 3rd Faculty of Medicine and FNKV University Hospital, Charles University, Prague, Czech Republic.

Michal Fric (M)

Department of Anaesthesiology and Intensive Care Medicine, 3rd Faculty of Medicine and FNKV University Hospital, Charles University, Prague, Czech Republic.

Kateřina Jiroutková (K)

Department of Anaesthesiology and Intensive Care Medicine, 3rd Faculty of Medicine and FNKV University Hospital, Charles University, Prague, Czech Republic.

Kamila Řasová (K)

Department of Rehabilitation, 3rd Faculty of Medicine and FNKV University Hospital, Charles University, Prague, Czech Republic.

František Duška (F)

Department of Anaesthesiology and Intensive Care Medicine, 3rd Faculty of Medicine and FNKV University Hospital, Charles University, Prague, Czech Republic frantisek.duska@lf3.cuni.cz.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH